AMPAC Fine Chemicals
AMPAC Fine Chemicals is a US-based CDMO founded in 2005, headquartered in Rancho Cordova, California, specializing in fine chemicals, controlled substances, and highly potent APIs for pharmaceutical drugmakers across preclinical through commercial stages.
- Company typePrivate
- Founded2005
- HeadquartersRancho Cordova, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What AMPAC Fine Chemicals does
AMPAC Fine Chemicals is a US-based specialty chemicals firm founded in 2005 and headquartered in Rancho Cordova, California. The company operates in the small-molecule pharmaceutical CDMO space, producing fine chemicals, controlled substances, and highly potent active pharmaceutical ingredients (HPAPIs) under cGMP compliance. With a workforce of 501–1,000 employees, AMPAC serves pharmaceutical drugmakers across the full drug development lifecycle, from preclinical stages through commercial manufacturing.
The firm's technical platform combines advanced analytical instrumentation — including LC-HRMS, LC-MS/MS, GC-MS, NMR spectroscopy (1H, 13C, 31P, 19F), XRPD, DSC, TGA, ICP-MS/OES, SEM, Malvern Mastersizer, and Morphologi G3 — with manufacturing capabilities such as continuous flow processing and biocatalysis/catalyst design. Specialized service lines include nitrosamine and genotoxic impurity testing, high-potency/cytotoxic API release testing, reference standard qualification, physical characterization, and stability/forced degradation studies. Operations span facilities in the United States, Ireland, and South Korea.
AMPAC's business model is a fee-for-service CDMO contract structure with quote-based project pricing and multi-year contractual engagements. The go-to-market motion is direct enterprise sales targeting pharmaceutical companies, supported by industry events, technical content marketing, LinkedIn presence, and direct inquiry channels. The firm emphasizes collaborative partnerships and regulatory compliance as core value drivers, though no specific customer logos, revenue figures, or ownership structure details are publicly disclosed.
AMPAC Fine Chemicals firmographics
Firmographics- Name
- AMPAC Fine Chemicals
- Website
- https://ampacfinechemicals.com
- Company type
- Private
- Founded year
- 2005
- Headcount range
- 501–1,000 employees
- Short description
- AMPAC Fine Chemicals is a US-based CDMO founded in 2005, headquartered in Rancho Cordova, California, specializing in fine chemicals, controlled substances, and highly potent APIs for pharmaceutical drugmakers across preclinical through commercial stages.
- Ownership category
- akta.pro rank
AMPAC Fine Chemicals industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing (CDMO)
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Chemical Manufacturing (325)
- SIC
- Pharmaceutical Preparations (2834), Industrial Organic Chemicals (2860), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Small-Molecule API & Intermediates CDMO (HLAGABAA)
- akta.pro secondary industries
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Controlled Substances / DEA-Scheduled API Manufacturing (HLAGAHAD), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)
Keywords
Where AMPAC Fine Chemicals is headquartered
LocationHeadquarters
- HQ city
- Rancho Cordova
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
AMPAC Fine Chemicals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Contract Analytical Testing Services: SK pharmteco operates as a CDMO providing fee-for-service analytical testing and development to pharmaceutical companies. Revenue is generated through contractual engagements for method development, validation, release testing, and stability studies across drug development phases.
- API Manufacturing Services: Custom API contract manufacturing including clinical trial materials, validation batches, and commercial manufacturing services for small molecules.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based pricing tailored to client needs |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
AMPAC Fine Chemicals product offering
Product offeringCore offering
AMPAC Fine Chemicals is a US-based contract manufacturer of fine chemicals, controlled substances, and highly potent active pharmaceutical ingredients (APIs) for pharmaceutical companies. As part of the SK pharmteco CDMO network, it provides custom API manufacturing across clinical and commercial phases, alongside cGMP-compliant analytical testing services such as method development, validation, release testing, stability studies, and nitrosamine/genotoxic impurity testing.
Differentiator
Problem solved
Functional benefit
Products and services
- Custom API Manufacturing Services
- Small Molecule Analytical & Testing Services
- Fine Chemicals Custom Manufacturing
- Controlled Substance API Manufacturing Specialized cGMP-compliant contract manufacturing of controlled substance APIs for pharmaceutical drugmakers, including handling of DEA-regulated substances and high-potency compounds.
- Highly Potent API Manufacturing Contract manufacturing of highly potent and cytotoxic APIs under strict cGMP compliance with specialized containment capabilities for pharmaceutical clients.
- Continuous Flow Processing Services Small molecule manufacturing services leveraging continuous flow processing capabilities for pharmaceutical clients, enabling improved safety, scalability, and process control for complex chemistries.
- Biocatalysis and Catalyst Design Services Specialized process development services in catalyst design and biocatalysis to support efficient and selective small molecule manufacturing for pharmaceutical clients.
Companies that use AMPAC Fine Chemicals
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
AMPAC Fine Chemicals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
AMPAC Fine Chemicals partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Jayhawk Fine Chemicals LLCcoreAnupam Rasayan India Ltd acquired US-based Jayhawk Fine Chemicals LLC for $150 million to establish a US manufacturing presence. The deal includes an investment of about $40 million from the Indian company and $110 million from a global investment management firm. This acquisition provides onshore US manufacturing capabilities.
Scale indicators2 records
Recent moves4 records
Expansion highlights4 records
AMPAC Fine Chemicals competitors and assessment
Company assessmentDirect peers
- Cambrex: Pure-play small-molecule API CDMO offering custom development, analytical services, and commercial manufacturing — directly comparable to AMPAC's core offering and customer base.
- Hovione: Specialty small-molecule API CDMO with expertise in highly potent APIs, particle engineering, and continuous manufacturing — competes head-to-head with AMPAC in HPAPI and complex chemistry niches.
- Piramal Pharma Solutions: Global CDMO offering API development, HPAPI manufacturing, and integrated drug-substance/drug-product services — directly comparable in scope, scale, and customer profile to AMPAC.
- AGC Pharma Chemicals (AGC Biologics / AGC Chemicals): Specialty CDMO offering small-molecule API development and manufacturing, including HPAPIs — competes in similar customer segment with comparable custom synthesis capabilities.
- Johnson Matthey (Pharma Services): Pharma services division offering API development, HPAPI handling, and catalysis expertise — directly comparable in technologies (catalysis, flow chemistry) and customer base to AMPAC.
- Noramco: Leading controlled-substance and API CDMO serving pharma — directly comparable to AMPAC's controlled-substances and HPAPI niche, with similar DEA-regulated infrastructure.
Broad incumbents
- Lonza Small Molecules: World's largest CDMO with deep small-molecule API capabilities alongside biologics. Overlaps directly with AMPAC but is much broader in scale and integrated offering.
- Catalent: Major global CDMO with API and drug-product services that overlap AMPAC's offering, though Catalent is more diversified across biologics, softgel, and oral dose forms.
- WuXi STA (WuXi AppTec): Large Chinese-headquartered CDMO offering comprehensive small-molecule API and drug-product services — competes with AMPAC especially on cost-driven commercial API work, with increasing US/EU presence.
- Thermo Fisher Scientific (Patheon): Global CDMO offering API and drug-product services as part of its broader pharma services franchise — overlaps with AMPAC's integrated CDMO offering at much larger scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
AMPAC Fine Chemicals social profiles
Digital presenceAMPAC Fine Chemicals financial estimates
Financial estimateRevenue estimate
Valuation estimate
AMPAC Fine Chemicals leadership team
Management profileNumber of profiles
AMPAC Fine Chemicals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AMPAC Fine Chemicals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AMPAC Fine Chemicals
What does AMPAC Fine Chemicals do?
AMPAC Fine Chemicals is a US-based contract manufacturer of fine chemicals, controlled substances, and highly potent active pharmaceutical ingredients (APIs) for pharmaceutical companies. As part of the SK pharmteco CDMO network, it provides custom API manufacturing across clinical and commercial phases, alongside cGMP-compliant analytical testing services such as method development, validation, release testing, stability studies, and nitrosamine/genotoxic impurity testing.
When was AMPAC Fine Chemicals founded?
AMPAC Fine Chemicals was founded in 2005. It employs 501 to 1,000 people.
Where is AMPAC Fine Chemicals based?
AMPAC Fine Chemicals is headquartered in Rancho Cordova, United States, in the North America region.
How does AMPAC Fine Chemicals make money?
Two revenue lines are on record. Contract Analytical Testing Services are the primary driver. The others are API Manufacturing Services.
Who are AMPAC Fine Chemicals's main competitors?
Direct peers on record are Cambrex, Hovione, Piramal Pharma Solutions, AGC Pharma Chemicals (AGC Biologics / AGC Chemicals), Johnson Matthey (Pharma Services) and Noramco. Broad incumbents are Lonza Small Molecules, Catalent, WuXi STA (WuXi AppTec) and Thermo Fisher Scientific (Patheon).
Does AMPAC Fine Chemicals have an API?
No public API is recorded for AMPAC Fine Chemicals.
What industry is AMPAC Fine Chemicals in?
AMPAC Fine Chemicals's product category is Pharmaceutical Contract Manufacturing (CDMO). Its primary akta.pro industry code is HLAGABAA, Small-Molecule API & Intermediates CDMO, with a secondary code of HLAGABAG, Drug Substance–Drug Product Integrated CDMO. Its NAICS code is 32541 and its SIC code is 2834.